يعرض 1 - 10 نتائج من 217 نتيجة بحث عن '"TOXINAS BOTULINICAS"', وقت الاستعلام: 0.96s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية

    المصدر: ANALES DE LA REAL ACADEMIA DE MEDICINA Y CIRUGÍA DE VALLADOLID; No. 56 (2020); 415-441 ; ANALES DE LA REAL ACADEMIA DE MEDICINA Y CIRUGÍA DE VALLADOLID; Núm. 56 (2020); 415-441 ; 2530-6421 ; 10.24197/aramcv.56.2020

    وصف الملف: application/pdf

    العلاقة: https://revistas.uva.es/index.php/anamedi/article/view/7862/5549Test; Xiao Z, Zhang F, Lin W, Zhang M, Liu Y. Effect of botulinum toxin type A on transforming growth factor beta1 in fibroblasts derived from hypertrophic scar: a preliminary report. Aesthetic Plast Surg. 2010 Aug;34(4):424–7.; Xiao Z, Zhang M, Liu Y, Ren L. Botulinum toxin type a inhibits connective tissue growth factor expression in fibroblasts derived from hypertrophic scar. Aesthetic Plast Surg. 2011 Oct;35(5):802–7.; Sohrabi C, Goutos I. The use of botulinum toxin in keloid scar management: a literature review. Scars, Burn Heal. 2020; 6:2059513120926628.; Tan S, Khumalo N, Bayat A. Understanding Keloid Pathobiology from a Quasi-Neoplastic Perspective: Less of a Scar and More of a Chronic Inflammatory Disease with Cancer-Like Tendencies. Front Immunol. 2019; 10:1810.; Lee HJ, Jang YJ. Recent Understandings of Biology, Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids. Int J Mol Sci. 2018 Mar;19(3).; Zhu Z, Ding J, Tredget EE. The molecular basis of hypertrophic scars. Burn trauma. 2016; 4:2.; Järveläinen H, Sainio A, Wight TN. Pivotal role for decorin in angiogenesis. Matrix Biol. 2015 Apr; 43:15–26.; Rasaii S, Sohrabian N, Gianfaldoni S, Hadibarhaghtalab M, Pazyar N, Bakhshaeekia A, et al. Intralesional triamcinolone alone or in combination with botulinium toxin A is ineffective for the treatment of formed keloid scar: A double blind controlled pilot study. Dermatol Ther. 2019 Mar;32(2): e12781.; Shaarawy E, Hegazy RA, Abdel Hay RM. Intralesional botulinum toxin type A equally effective and better tolerated than intralesional steroid in the treatment of keloids: a randomized controlled trial. J Cosmet Dermatol. 2015 Jun;14(2):161–6.; Scala J, Vojvodic A, Vojvodic P, Vlaskovic-Jovicevic T, Peric-Hajzler Z, Matovic D, et al. Botulinum Toxin Use in Scars/Keloids Treatment. Open access Maced J Med Sci. 2019 Sep;7(18):2979–81.; Xu D, Zhang D-S, Hu X-F, Hu M-Y. Evaluation of the efficiency and safety of botulinum toxin A injection on improving facial scars: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2021 Jan;100(1): e23034.; Oryan A, Alemzadeh E. Comparison of botulinum toxin type A and aprotinin monotherapy with combination therapy in healing of burn wounds in an animal model. Mol Biol Rep. 2020 Apr;47(4):2693–702.; Hu C-H, Tseng Y-W, Lee C-W, Chiou C-Y, Chuang S-S, Yang J-Y, et al. Combination of mesenchymal stem cell-conditioned medium and botulinum toxin type A for treating human hypertrophic scars. J Plast Reconstr Aesthet Surg. 2020 Mar;73(3):516–27.; Xiaoxue W, Xi C, Zhibo X. Effects of botulinum toxin type A on expression of genes in keloid fibroblasts. Aesthetic Surg J. 2014 Jan;34(1):154–9.; Zhibo X, Miaobo Z. Botulinum toxin type A affects cell cycle distribution of fibroblasts derived from hypertrophic scar. Vol. 61, Journal of plastic, reconstructive & aesthetic surgery: JPRAS. Netherlands; 2008. p. 1128–9.; Jeong HS, Lee BH, Sung HM, Park SY, Ahn DK, Jung MS, et al. Effect of Botulinum Toxin Type A on Differentiation of Fibroblasts Derived from Scar Tissue. Plast Reconstr Surg. 2015 Aug;136(2):171e-178e.; Ogawa R. Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis. Int J Mol Sci. 2017 Mar;18(3).; Çalıskan E, Gamsızkan M, Açıkgöz G, Durmuş M, Toklu S, Doğrul A, et al. Intralesional treatments for hypertrophic scars: comparison among corticosteroid, 5-fluorouracil and botulinum toxin in rabbit ear hypertrophic scar model. Eur Rev Med Pharmacol Sci. 2016 Apr;20(8):1603–8.; Liu D-Q, Li X-J, Weng X-J. Effect of BTXA on Inhibiting Hypertrophic Scar Formation in a Rabbit Ear Model. Aesthetic Plast Surg. 2017 Jun;41(3):721–8.; Fanous A, Bezdjian A, Caglar D, Mlynarek A, Fanous N, Lenhart SF, et al. Treatment of Keloid Scars with Botulinum Toxin Type A versus Triamcinolone in an Athymic Nude Mouse Model. Plast Reconstr Surg. 2019 Mar;143(3):760–7.; Gamil HD, Khattab FM, El Fawal MM, Eldeeb SE. Comparison of intralesional triamcinolone acetonide, botulinum toxin type A, and their combination for the treatment of keloid lesions. J Dermatolog Treat. 2020 Aug;31(5):535–44.; Pruksapong C, Yingtaweesittikul S, Burusapat C. Efficacy of Botulinum Toxin A in Preventing Recurrence Keloids: Double Blinded Randomized Controlled Trial Study: Intraindividual Subject. J Med Assoc Thai. 2017 Mar;100(3):280–6.; Li J, Wu X, Chen D. Observation on clinical efficacy of intralesional injection of glucocorticoid combined with botulinum toxin type A for treatment of keloid. Journal of Clinical Dermatology. 2017; 46(9):629-632. 24. Zhou M, Wang L, Rihua J, et al. Evaluation on efficacy and adverse reactions of combined therapy with botulinum toxin type A in treatment of keloid. J Jilin Univ (Medicine Ed) 2017; 43: 386–390.; https://revistas.uva.es/index.php/anamedi/article/view/7862Test

  4. 4
    دورية أكاديمية

    المؤلفون: Meza Meza, Paola Michelle

    المساهمون: Tintín Rea, José Fernando, 0706971827, .

    المصدر: Universidad Católica de Cuenca ; Repositorio Institucional - UCACUE

    الوقت: Azogues-Ecuador

    وصف الملف: application/pdf; x, 21 páginas

    العلاقة: http://creativecommons.org/licenses/by/4.0/deed.esTest; Meza Meza, P.M. (2023) "Eficacia de la toxina botulínica vs gingivectomía en el tratamiento de sonrisa gingival". Universidad Católica de Cuenca.; 10BT2023-TOdo-14; https://dspace.ucacue.edu.ec/handle/ucacue/13858Test

  5. 5
    دورية أكاديمية

    المؤلفون: Armijos Ayala, Anthony Daniel

    المساهمون: Chunchi Ayala, Luis Mario, 0302227020

    المصدر: Universidad Católica de Cuenca ; Repositorio Institucional - UCACUE

    الوقت: Cuenca - Ecuador

    وصف الملف: application/pdf; 16 páginas

    العلاقة: Armijos Ayala AD, Chunchi Ayala LM. Utilidad de la toxina botulínica en el tratamiento de migraña crónica. CD [Internet]. 5 de enero de 2023 [citado 5 de abril de 2024];7(1):97-112. Disponible en: https://cienciadigital.org/revistacienciadigital2/index.php/CienciaDigital/article/view/2447Test; https://doi.org/10.33262/cienciadigital.v7i1.2447Test; CIENCIA DIGITAL; 9BT2023-MTI287; https://dspace.ucacue.edu.ec/handle/ucacue/17185Test

  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية
  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية